Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2023 Filed Aug 8, 2023 00:47 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
SaleOrdinary Shares | 1,352 | $84.11 | $113,716.72 |
DisclosureSEC source: 0001613103-23-000104 · wk-form4_1691455620.xml · nonDerivative · entry 3 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,930 F4 · shares: This transaction was made pursuant to Mr. Marinaro's existing Rule 10b5-1 plan. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:23 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
Exercise / conversionPerformance Share Units · Derivative | 5,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000101 · wk-form4_1691454193.xml · derivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 5,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 3, 2023. F6 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:23 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
Tax withholdingOrdinary Shares | 4,065 | $84.49 | $343,451.85 |
DisclosureSEC source: 0001613103-23-000101 · wk-form4_1691454193.xml · nonDerivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,965 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:23 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
GrantOrdinary Shares | 5,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000101 · wk-form4_1691454193.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,030 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 61 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:22 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionPerformance Share Units · Derivative | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000100 · wk-form4_1691454149.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 5,168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 3, 2023. F5 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:22 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 4,284 | $84.49 | $361,955.16 |
DisclosureSEC source: 0001613103-23-000100 · wk-form4_1691454149.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,573 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:22 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000100 · wk-form4_1691454149.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,857 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 55 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:19 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
Exercise / conversionPerformance Share Units · Derivative | 7,105 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613103-23-000096 · wk-form4_1691453938.xml · derivative · entry 7 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 7,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 3, 2023. F6 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:19 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
Tax withholdingOrdinary Shares | 5,919 | $84.49 | $500,096.31 |
DisclosureSEC source: 0001613103-23-000096 · wk-form4_1691453938.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,327 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:19 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GrantOrdinary Shares | 7,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000096 · wk-form4_1691453938.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,246 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 723 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Exercise / conversionPerformance Share Units · Derivative | 6,217 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613103-23-000098 · wk-form4_1691454046.xml · derivative · entry 3 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 6,217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 3, 2023. F5 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Tax withholdingOrdinary Shares | 4,693 | $84.49 | $396,511.57 |
DisclosureSEC source: 0001613103-23-000098 · wk-form4_1691454046.xml · nonDerivative · entry 2 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,723 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
GrantOrdinary Shares | 6,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000098 · wk-form4_1691454046.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,416 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 32 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:17 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionPerformance Share Units · Derivative | 18,165 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613103-23-000095 · wk-form4_1691453863.xml · derivative · entry 3 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Unit · 18,165 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 3, 2023. F5 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:17 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Tax withholdingOrdinary Shares | 17,965 | $84.49 | $1,517,862.85 |
DisclosureSEC source: 0001613103-23-000095 · wk-form4_1691453863.xml · nonDerivative · entry 2 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,144 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:17 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
GrantOrdinary Shares | 18,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000095 · wk-form4_1691453863.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,109 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 1,847 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:21 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Exercise / conversionPerformance Share Units · Derivative | 4,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000099 · wk-form4_1691454101.xml · derivative · entry 3 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Unit · 4,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 3, 2023. F5 · derivative.expiration_date: The performance share units vested on August 3, 2023. F4 · balance_after: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:21 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Tax withholdingOrdinary Shares | 4,051 | $84.49 | $342,268.99 |
DisclosureSEC source: 0001613103-23-000099 · wk-form4_1691454101.xml · nonDerivative · entry 2 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,748 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:21 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
GrantOrdinary Shares | 4,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000099 · wk-form4_1691454101.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,799 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 49 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:47 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Exercise / conversionPerformance Share Unit · Derivative | 1,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000104 · wk-form4_1691455620.xml · derivative · entry 4 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 1,696 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 3, 2023. F6 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:47 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Tax withholdingOrdinary Shares | 1,323 | $84.49 | $111,780.27 |
DisclosureSEC source: 0001613103-23-000104 · wk-form4_1691455620.xml · nonDerivative · entry 2 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,282 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:47 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
GrantOrdinary Shares | 1,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000104 · wk-form4_1691455620.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,605 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 19 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:23 UTC |
Kirk Jennifer MChief Accounting Officer
|
Exercise / conversionPerformance Share Units · Derivative | 1,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000102 · wk-form4_1691454230.xml · derivative · entry 3 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 1,178 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F3 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: The performance share units vested on August 3, 2023. F4 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:23 UTC |
Kirk Jennifer MChief Accounting Officer
|
Tax withholdingOrdinary Shares | 361 | $84.49 | $30,500.89 |
DisclosureSEC source: 0001613103-23-000102 · wk-form4_1691454230.xml · nonDerivative · entry 2 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,193 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:23 UTC |
Kirk Jennifer MChief Accounting Officer
|
GrantOrdinary Shares | 1,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000102 · wk-form4_1691454230.xml · nonDerivative · entry 1 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,554 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionPerformance Share Units · Derivative | 5,604 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613103-23-000097 · wk-form4_1691454000.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Unit · 5,604 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 3, 2023. F5 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC |
Salmon SeanEVP & President Cardiovascular
|
Tax withholdingOrdinary Shares | 4,369 | $84.49 | $369,136.81 |
DisclosureSEC source: 0001613103-23-000097 · wk-form4_1691454000.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,726 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC |
Salmon SeanEVP & President Cardiovascular
|
GrantOrdinary Shares | 5,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000097 · wk-form4_1691454000.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,095 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 201 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:22 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
GrantStock Option (Right to Buy) · Derivative | 64,185 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000084 · wk-form4_1691022114.xml · derivative · entry 3 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,185 Underlying: Ordinary Shares · 64,185 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:22 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
GrantPerformance Share Units · Derivative | 22,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000084 · wk-form4_1691022114.xml · derivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,790 Underlying: Performance Share Unit · 22,790 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 22,790 shares will be issued. If maximum performance metrics are achieved, 45,580 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:22 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
GrantOrdinary Shares | 9,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000084 · wk-form4_1691022114.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,156 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 544 units acquired through dividend reinvestment and 310 units acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:13 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 68,196 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000082 · wk-form4_1691021627.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,196 Underlying: Ordinary Shares · 68,196 shares Expires 2033-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:13 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
GrantPerformance Share Units · Derivative | 24,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000082 · wk-form4_1691021627.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,214 Underlying: Performance Share Unit · 24,214 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,214 shares will be issued. If maximum performance metrics are achieved, 48,428 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F4 · derivative.exercise_date: Vests on July 31, 2026. F4 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:13 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
GrantOrdinary Shares | 9,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000082 · wk-form4_1691021627.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,634 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 19:46 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
GrantStock Option (Right to Buy) · Derivative | 56,162 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000072 · wk-form4_1691019985.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,162 Underlying: Ordinary Shares · 56,162 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 19:46 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
GrantPerformance Share Units · Derivative | 19,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000072 · wk-form4_1691019985.xml · derivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,941 Underlying: Performance Share Units · 19,941 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,941 shares will be issued. If maximum performance metrics are achieved, 39,882 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 19:46 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
GrantOrdinary Shares | 7,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000072 · wk-form4_1691019985.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,807 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 641 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:43 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 88,254 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000070 · wk-form4_1691019823.xml · derivative · entry 7 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,254 Underlying: Ordinary Shares · 88,254 shares Expires 2033-07-31 F7 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:43 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 31,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000070 · wk-form4_1691019823.xml · derivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,336 Underlying: Performance Share Unit · 31,336 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,336 shares will be issued. If maximum performance metrics are achieved, 62,672 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F6 · derivative.exercise_date: Vests on July 31, 2026. F6 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:43 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GrantOrdinary Shares | 12,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000070 · wk-form4_1691019823.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,418 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 921 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:01 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
GrantStock Option (Right to Buy) · Derivative | 64,185 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000078 · wk-form4_1691020862.xml · derivative · entry 3 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,185 Underlying: Ordinary Shares · 64,185 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:01 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
GrantPerformance Share Units · Derivative | 22,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000078 · wk-form4_1691020862.xml · derivative · entry 2 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,790 Underlying: Performance Share Unit · 22,790 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 22,790 shares will be issued. If maximum performance metrics are achieved, 45,580 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:01 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
GrantOrdinary Shares | 26,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000078 · wk-form4_1691020862.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,167 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 379 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:39 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
GrantStock Option (Right to Buy) · Derivative | 240,691 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000068 · wk-form4_1691019553.xml · derivative · entry 3 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,382 Underlying: Ordinary Shares · 240,691 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:39 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
GrantPerformance Share Units · Derivative | 85,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000068 · wk-form4_1691019553.xml · derivative · entry 2 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,461 Underlying: Performance Share Units · 85,461 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 85,461 shares will be issued. If maximum performance metrics are achieved, 170,922 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:39 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
GrantOrdinary Shares | 34,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000068 · wk-form4_1691019553.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,097 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 2,415 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:09 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
GrantStock Option (Right to Buy) · Derivative | 60,173 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000080 · wk-form4_1691021356.xml · derivative · entry 3 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,173 Underlying: Ordinary Shares · 60,173 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:09 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
GrantPerformance Share Units · Derivative | 21,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000080 · wk-form4_1691021356.xml · derivative · entry 2 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,366 Underlying: Performance Share Unit · 21,366 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21366 shares will be issued. If maximum performance metrics are achieved, 42,732 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:09 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
GrantOrdinary Shares | 8,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000080 · wk-form4_1691021356.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,499 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 150 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:25 UTC |
Kirk Jennifer MChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,058 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000086 · wk-form4_1691022299.xml · derivative · entry 3 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,058 Underlying: Ordinary Shares · 20,058 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.